Fibrates and renal failure

This large cohort study of patients >age 65 found those with a new outpatient prescription for a fibrate were >2 times more likely to be hospitalized with an increased creatinine within 90 days, which was most pronounced in those with chronic kidney disease. New fibrate use in the elderly should carefully weigh the risk and benefit in light of these new findings, especially in those with chronic kidney disease (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment